| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33.
|
| [3] |
Primrose JN. Surgery for colorectal liver metastases [J]. Br J Cancer, 2010, 102(9): 1313-1318.
|
| [4] |
Haraldsdottir S, Wu C, Bloomston M, et al. What is the optimal neo-adjuvant treatment for liver metastasis? [J]. Ther Adv Med Oncol, 2013, 5(4): 221-234.
|
| [5] |
Tejpar S, Stintzing S, Ciardiello F, et al. Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials[J]. JAMA Oncol, 2017, 3(2): 194-201.
|
| [6] |
卢婧, 孙祺, 车向明. 潜在可切除的结直肠癌同时性肝转移的治疗策略[J]. 现代肿瘤医学, 2021, 29(18): 3317-3320.
|
| [7] |
Andre T, Shiu KK, Kim TW, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer [J]. N Engl J Med, 2020, 383(23): 2207-2218.
|
| [8] |
Chalabi M, Fanchi LF, Dijkstra KK, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers [J]. Nat Med, 2020, 26(4): 566-576.
|
| [9] |
Molla M, Fernandez-Plana J, Albiol S, et al. Limited liver or lung colorectal cancer metastases. systemic treatment, surgery, ablation or SBRT[J]. J Clin Med, 2021, 10(10): 2131.
|
| [10] |
Kambakamba P, Hoti E, Cremen S, et al. The evolution of surgery for colorectal liver metastases: A persistent challenge to improve survival [J]. Surgery, 2021, 170(6):1732-1740.
|
| [11] |
张炜力, 周驰, 邓宇翔, 等. 初始不可切除结直肠癌肝转移转化治疗结局影响因素分析[J]. 中华胃肠外科杂志, 2022, 25(1): 56-62.
|
| [12] |
张钰洋, 陈善稳, 王鹏远, 等. 结直肠癌肝转移转化治疗的研究进展[J]. 中华胃肠外科杂志, 2021, 24(1): 85-93.
|
| [13] |
Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy [J]. JAMA Oncol, 2019, 5(4): e185896.
|
| [14] |
Fernandez LM, São Julião GP, Figueiredo NL, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study [J]. The Lancet Oncology, 2021, 22(1): 43-50.
|
| [15] |
López-campos F, Martín-martín M, Fornell-pérez R, et al. Watch and wait approach in rectal cancer: Current controversies and future directions[J]. World J Gastroenterol, 2020, 26(29): 4218-4239.
|